Search research articles
Contact Us
Filters
Showing results (871-880 of 986) with videos related to
Page
of 99
Sort By:
Prenatal Diagnosis
|
November 27, 2008
Down syndrome serum screening also identifies an increased risk for multicystic dysplastic kidney, two-vessel cord, and hydrocele
Jodi D Hoffman, Diana W Bianchi, Lisa M Sullivan, et al.
Archives of Pathology & Laboratory Medicine
|
March 1, 2014
The pathology milestones and the next accreditation system
Wesley Y Naritoku, C Bruce Alexander, Betsy D Bennett, et al.
The Journal of Allergy and Clinical Immunology
|
April 22, 2018
Eleven loci with new reproducible genetic associations with allergic disease risk
Manuel A R Ferreira, Judith M Vonk, Hansjörg Baurecht, et al.
Journal of Medicinal Chemistry
|
March 7, 2018
Discovery of [ cis-3-({(5 R)-5-[(7-Fluoro-1,1-dimethyl-2,3-dihydro-1 H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5 H)-yl}carbonyl)cyclobutyl]acetic Acid (TAK-828F) as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist
Mitsunori Kono, Atsuko Ochida, Tsuneo Oda, et al.
Journal of Geodesy
|
January 11, 2020
Modernizing and Expanding the NASA Space Geodesy Network to Meet Future Geodetic Requirements
S M Merkowitz, S Bolotin, P Elosegui, et al.
ACS Medicinal Chemistry Letters
|
October 18, 2019
Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding Mode
Jun Fujimoto, Osamu Kurasawa, Terufumi Takagi, et al.
Nature Communications
|
September 5, 2020
Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts
Sara R Rashkin, Rebecca E Graff, Linda Kachuri, et al.
Physical Review Letters
|
September 10, 2025
Demonstration of a Novel Radiochemical Mix Diagnostic for Fusion Implosions at the National Ignition Facility
S A MacLaren, E L Dewald, D A Martinez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2021
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors
Corey C Foster, Gini F Fleming, Theodore G Karrison, et al.
Nature Communications
|
February 13, 2021
Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts
Rebecca E Graff, Taylor B Cavazos, Khanh K Thai, et al.
Page
of 99
Search research articles
Search
Showing results (871-880 of 986) with videos related to
Sort By:
Page
of 99
Prenatal Diagnosis
|
November 27, 2008
Down syndrome serum screening also identifies an increased risk for multicystic dysplastic kidney, two-vessel cord, and hydrocele
Jodi D Hoffman, Diana W Bianchi, Lisa M Sullivan, et al.
Archives of Pathology & Laboratory Medicine
|
March 1, 2014
The pathology milestones and the next accreditation system
Wesley Y Naritoku, C Bruce Alexander, Betsy D Bennett, et al.
The Journal of Allergy and Clinical Immunology
|
April 22, 2018
Eleven loci with new reproducible genetic associations with allergic disease risk
Manuel A R Ferreira, Judith M Vonk, Hansjörg Baurecht, et al.
Journal of Medicinal Chemistry
|
March 7, 2018
Discovery of [ cis-3-({(5 R)-5-[(7-Fluoro-1,1-dimethyl-2,3-dihydro-1 H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5 H)-yl}carbonyl)cyclobutyl]acetic Acid (TAK-828F) as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist
Mitsunori Kono, Atsuko Ochida, Tsuneo Oda, et al.
Journal of Geodesy
|
January 11, 2020
Modernizing and Expanding the NASA Space Geodesy Network to Meet Future Geodetic Requirements
S M Merkowitz, S Bolotin, P Elosegui, et al.
ACS Medicinal Chemistry Letters
|
October 18, 2019
Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding Mode
Jun Fujimoto, Osamu Kurasawa, Terufumi Takagi, et al.
Nature Communications
|
September 5, 2020
Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts
Sara R Rashkin, Rebecca E Graff, Linda Kachuri, et al.
Physical Review Letters
|
September 10, 2025
Demonstration of a Novel Radiochemical Mix Diagnostic for Fusion Implosions at the National Ignition Facility
S A MacLaren, E L Dewald, D A Martinez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2021
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors
Corey C Foster, Gini F Fleming, Theodore G Karrison, et al.
Nature Communications
|
February 13, 2021
Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts
Rebecca E Graff, Taylor B Cavazos, Khanh K Thai, et al.
Page
of 99